Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Esperion Therap(ESPR) the Revenue is 80.1 M (+23.25%);the EBIT is -6.581 M (+70.22%);the EPS is -0.1 (+51.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.08B23.25%
----
----
EBIT
-0.01B70.22%
----
----
EPS
-0.100251.40%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf